Shannon D. Barker, Ph.D.

Affiliations: 
2002 University of Alabama, Birmingham, Birmingham, AL, United States 
Google:
"Shannon Barker"
Mean distance: 22.94 (cluster 59)
 

Parents

Sign in to add mentor
David T. Curiel grad student 2002 UAB
 (The regulatory sequences of the secretory leukoprotease inhibitor gene as a tissue -specific promoter for gene therapy of ovarian carcinoma.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Burnip E, Owen SJ, Barker S, et al. (2013) Swallowing outcomes following surgical and non-surgical treatment for advanced laryngeal cancer. The Journal of Laryngology and Otology. 127: 1116-21
Raoul C, Barker SD, Aebischer P. (2006) Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Therapy. 13: 487-95
Ono HA, Davydova JG, Adachi Y, et al. (2005) Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. Journal of Gastroenterology. 40: 31-42
Zhu ZB, Makhija SK, Lu B, et al. (2004) Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Therapy. 11: 256-62
Barker SD, Dmitriev IP, Nettelbeck DM, et al. (2003) Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma. Gene Therapy. 10: 1198-204
Lam JT, Bauerschmitz GJ, Kanerva A, et al. (2003) Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids. Cancer Gene Therapy. 10: 377-87
Barker SD, Coolidge CJ, Kanerva A, et al. (2003) The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy. The Journal of Gene Medicine. 5: 300-10
Nagi P, Vickers SM, Davydova J, et al. (2003) Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement Journal of Gastrointestinal Surgery. 7: 364-371
Hakkarainen T, Hemminki A, Pereboev AV, et al. (2003) CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 619-24
Bauerschmitz GJ, Barker SD, Hemminki A. (2002) Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). International Journal of Oncology. 21: 1161-74
See more...